Emerging Treatment for Anemia of CKD: HIF-PH Inhibitors
b'Guest: Jay Wish, MD
\\n\\n\\n \\n
In this activity, Dr. Jay Wish, Chief Medical Officer for Outpatient Dialysis in the Division of Nephrology at Indiana University Health, discusses emerging treatment for Anemia of chronic kidney disease (CKD), specifically with hypoxia-inducible factor\\u2013prolyl hydroxylase domain (HIF-PH) inhibitors.
'